Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 20, 2022

BUY
$246.08 - $343.65 $1,230 - $1,718
5 Added 21.74%
28 $7,000
Q2 2022

Jul 26, 2022

SELL
$280.61 - $420.45 $2,525 - $3,784
-9 Reduced 28.13%
23 $7,000
Q3 2021

Nov 16, 2021

SELL
$363.01 - $468.47 $4,719 - $6,090
-13 Reduced 28.89%
32 $14,000
Q2 2021

Aug 16, 2021

SELL
$284.77 - $363.2 $854 - $1,089
-3 Reduced 6.25%
45 $16,000
Q3 2020

Nov 10, 2020

SELL
$224.99 - $288.02 $4,724 - $6,048
-21 Reduced 30.43%
48 $13,000
Q2 2020

Sep 11, 2020

BUY
$149.8 - $227.17 $10,336 - $15,674
69 New
69 $16,000
Q2 2020

Aug 14, 2020

SELL
$149.8 - $227.17 $10,336 - $15,674
-69 Closed
0 $0
Q3 2019

Oct 29, 2019

SELL
$121.41 - $150.02 $4,613 - $5,700
-38 Reduced 35.51%
69 $10,000
Q4 2018

Feb 11, 2019

BUY
$93.0 - $123.98 $9,951 - $13,265
107 New
107 $10,000

Others Institutions Holding WST

About WEST PHARMACEUTICAL SERVICES INC


  • Ticker WST
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 74,033,000
  • Market Cap $24.6B
  • Description
  • West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...
More about WST
Track This Portfolio

Track Fin Trust Capital Advisors, LLC Portfolio

Follow Fin Trust Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fin Trust Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fin Trust Capital Advisors, LLC with notifications on news.